Danaher Corp. agrees to fork over $6.8 billion, or $83.50 per share, for diagnostics giant Beckman Coulter Inc. Danaher Corp. (NYSE:DHR) agreed to pay about $6.8 billion in cash for Beckman Coulter ...

Bio-Hermes-002 is the unique, observational platform study that compares blood-based and digital biomarkers across a broad range of clinical cognitive conditions, MRI and PET images as well as ...

BREA, Calif. & TOKYO--(BUSINESS WIRE)--Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today ...

(RTTNews) - Beckman Coulter Diagnostics, the clinical diagnostics unit of science and technology firm Danaher Corp. (DHR), announced Monday that the new DxC 500i Clinical Analyzer received 510(k) ...

BREA, Calif., Jan. 15, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in advanced diagnostics, today announced availability of new Research Use Only (RUO) blood-based biomarker ...

BREA, Calif., Sept. 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and a leader in global clinical diagnostics innovation, today launched the industry's first fully automated ...

Siemens Healthineers AG became the latest company to sign a licensing agreement with Alzpath Inc. to use its pTau217 antibody ...

Beckman Coulter Diagnostics, a global leader in the clinical diagnostic industry and headquartered out of Brea, CA, USA announced that it is ramping up its commercial focus on the Indian subcontinent ...

Diagnostic company SphingoTec GmbH (“SphingoTec”) announced a new partnership with Beckman Coulter Diagnostics Inc. (“Beckman Coulter”). Through this collaboration, the companies will bring an assay ...

Beckman Coulter, a global leader in diagnostics and infertility testing, announced today the launch of the first and only test that uses a validated cut-off to aid in the assessment of ovarian ...

Washington D.C., Jan. 23, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer's Platform Foundation® (GAP) is pleased to welcome Beckman Coulter Diagnostics as a strategic partner in the Bio-Hermes-002 ...